Hims & Hers Health Change in Accounts Receivable 2020-2025 | HIMS

Hims & Hers Health annual/quarterly change in accounts receivable history and growth rate from 2020 to 2025. Change in accounts receivable can be defined as the increase or decrease in accounts receivable for the given period.
  • Hims & Hers Health change in accounts receivable for the quarter ending March 31, 2025 was $0M, a 0% increase year-over-year.
  • Hims & Hers Health change in accounts receivable for the twelve months ending March 31, 2025 was $0M, a 0% increase year-over-year.
  • Hims & Hers Health annual change in accounts receivable for 2024 was $0B, a 0% decline from 2023.
  • Hims & Hers Health annual change in accounts receivable for 2023 was $0B, a 0% decline from 2022.
  • Hims & Hers Health annual change in accounts receivable for 2022 was $0B, a 0% decline from 2021.
Hims & Hers Health Annual Change in Accounts Receivable
(Millions of US $)
2024 $N/A
2023 $N/A
2022 $N/A
2021 $N/A
2020 $N/A
2019 $N/A
2018 $N/A
Sector Industry Market Cap Revenue
Medical Medical Information Systems $12.608B $1.477B
Hims & Hers Health Inc. is a multi-specialty telehealth platform that connects consumers to licensed healthcare professionals, enabling medical care for numerous conditions related to mental health, sexual health, dermatology, primary care and more. Hims & Hers Health Inc., formerly known as Oaktree Acquisition Corp., is based in San Francisco.
Stock Name Country Market Cap PE Ratio
Veeva Systems (VEEV) United States $46.427B 59.33
Tempus AI (TEM) United States $10.745B 0.00
IRhythm Technologies (IRTC) United States $4.683B 0.00
Inspire Medical Systems (INSP) United States $4.012B 62.68
Hinge Health (HNGE) United States $3.034B 0.00
Privia Health (PRVA) United States $2.827B 193.25
Enovis (ENOV) United States $1.816B 10.12
Schrodinger (SDGR) United States $1.807B 0.00
Phreesia (PHR) United States $1.595B 0.00
Clover Health Investments (CLOV) United States $1.555B 0.00
Omnicell (OMCL) United States $1.452B 25.62
Azenta (AZTA) United States $1.316B 61.17
10x Genomics (TXG) United States $1.160B 0.00
Fulgent Genetics (FLGT) United States $0.652B 0.00
Claritev (CTEV) United States $0.650B 0.00
Butterfly Network (BFLY) United States $0.613B 0.00
Talkspace (TALK) United States $0.550B 164.50
Veradigm (MDRX) United States $0.476B 0.00
Standard BioTools (LAB) United States $0.403B 0.00
Outset Medical (OM) United States $0.371B 0.00
TruBridge (TBRG) United States $0.358B 794.00
Health Catalyst (HCAT) United States $0.285B 0.00
Nyxoah SA (NYXH) Belgium $0.261B 0.00
SOPHiA GENETICS SA (SOPH) Switzerland $0.209B 0.00
KORU Medical Systems (KRMD) United States $0.142B 0.00
EUDA Health Holdings (EUDA) Singapore $0.128B 0.00
Pulmonx (LUNG) United States $0.128B 0.00
American Well (AMWL) United States $0.109B 0.00
MDxHealth SA (MDXH) Belgium $0.098B 0.00
CareCloud (CCLD) United States $0.092B 3.52
111 (YI) China $0.073B 0.00
HeartBeam (BEAT) United States $0.056B 0.00
P3 Health Partners (PIII) United States $0.048B 0.00
Zepp Health (ZEPP) Netherlands $0.034B 0.00
ImmunoPrecise Antibodies (IPA) Canada $0.031B 0.00
Zhongchao (ZCMD) China $0.027B 0.00
Streamline Health Solutions (STRM) United States $0.022B 0.00
Precipio (PRPO) United States $0.017B 0.00
Bullfrog AI Holdings (BFRG) United States $0.016B 0.00
MSP Recovery (MSPR) United States $0.012B 0.00
Strata Skin Sciences (SSKN) United States $0.010B 0.00
Predictive Oncology (POAI) United States $0.008B 0.00
Movano (MOVE) United States $0.005B 0.00
Evaxion - (EVAX) Denmark $0.004B 0.00
HeartSciences (HSCS) United States $0.004B 0.00
Mobile-health Network Solutions (MNDR) Singapore $0.004B 0.00
Tivic Health Systems (TIVC) United States $0.003B 0.00
Healthcare Triangle (HCTI) United States $0.000B 0.00
Future Health ESG (FHLT) United States $0.000B 0.00